Dr. Kim on the Role of Trastuzumab Deruxtecan in HER2-Mutated NSCLC - OncLive

Edward S. Kim, MD, MBA, discusses the importance of trastuzumab deruxtecan in HER2-mutated non–small cell lung cancer.

Edward S. Kim, MD, MBA, physician-in-chief at City of Hope Orange County and vice physician-in-Chief at City of Hope National Medical Center, discusses the importance of fam-trastuzumab deruxtecan-nx… [+887 chars]

full article...